HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

nandrolone decanoate (Decadurabolin)

Subscribe to New Research on nandrolone decanoate

structure; used in the treatment of HIV wasting disease

Also Known As:

Decadurabolin; 17 beta-hydroxyestr-4-en-3-one 17-decanoate; 19-nor-4-androstene-17 beta-ol-3-one 17-decanoate; 19-nortestosterone decanoate; Decadurobolin; Retabolil; Retabolyl

Networked: 150 relevant articles (8 outcomes, 31 trials/studies) for this Drug, Comments

Relationship Network

Drug Context: Research Results

Experts

1.	Frei, Fernando: 2 articles (09/2009 - 07/2005)
2.	Camargo, Isabel Cristina Cherici: 2 articles (09/2009 - 07/2005)
3.	Busato, Vera Cristina W: 2 articles (06/2009 - 01/2008)
4.	Tidermark, Jan: 2 articles (08/2007 - 08/2004)
5.	Tengstrand, Birgitta: 2 articles (08/2007 - 08/2004)
6.	Söderqvist, Anita: 2 articles (08/2007 - 08/2004)
7.	Cederholm, Tommy: 2 articles (08/2007 - 08/2004)
8.	Batterham, M J: 2 articles (04/2006 - 08/2001)
9.	Léoty, C: 2 articles (12/2002 - 07/2002)
10.	Joumaa, W H: 2 articles (12/2002 - 07/2002)

Related Diseases

1.	Anemia 01/01/2005 - "Our target is to assess the safety and the efficacy of nandrolone decanoate (ND) as an effective adjunctive therapy to treat such anemia. " 11/01/1988 - "Nandrolone decanoate therapy for anemia in patients on haemodialysis." 01/01/1999 - "OBJECTIVE: To assess the efficiency of nandrolone decanoate (ND) in the control of anemia in elderly male patients on hemodialysis (HD), and to determine its influence on nutritional parameters. " 01/01/1999 - "Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis." 04/01/1997 - "We have studied the changes in the lipid profile of 14 chronic hemodialysis patients receiving a 6-month cycle of nandrolone decanoate as treatment for anemia. " Order ALL the reference details at left...
2.	HIV Infections (HIV Infection) 06/01/1996 - "Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection." 05/01/2009 - "Recent studies have demonstrated the role of nandrolone decanoate (ND) in reversal of wasting associated with HIV infection. " 03/14/2005 - "CONCLUSION: Nandrolone decanoate therapy may prove to be generally safe and beneficial in reversing weight loss and lean tissue loss in women with HIV infection and other chronic catabolic diseases." Order ALL the reference details at left...
3.	Weight Loss (Weight Reduction) 03/14/2005 - "Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial." 02/01/1999 - "Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss." 07/01/1986 - "There was a trend for less severe weight loss on the nandrolone decanoate arm (average weight loss 0.8 +/- 0.15 kg versus 0.21 +/- 0.18 kg, respectively), with half as many patients experiencing weight loss on nandrolone decanoate (25% versus 12%). " 03/14/2005 - "METHODS: In this randomized, double-blind, placebo-controlled, multicenter, phase I/II study, 38 HIV-infected women with documented weight loss of 5% or greater in the preceding year or a body mass index of less than 20 kg/m(2) were randomized to receive nandrolone decanoate (100 mg) or an equivalent volume of placebo every other week by intramuscular injection. " 03/14/2005 - "CONCLUSION: Nandrolone decanoate therapy may prove to be generally safe and beneficial in reversing weight loss and lean tissue loss in women with HIV infection and other chronic catabolic diseases." Order ALL the reference details at left...
4.	Chronic Obstructive Pulmonary Disease (COPD) 10/01/1995 - "Two hundred seventeen patients with COPD participated in a placebo-controlled, randomized trial investigating the physiologic effects of nutritional intervention alone (N) for 8 wk or combined with the anabolic steroid nandrolone decanoate (N + A). " 01/01/2008 - "Sixteen patients with severe COPD were randomized to either placebo or nandrolone decanoate. " 01/01/2008 - "Administration of anabolic steroids (nandrolone decanoate) outside a dedicated rehabilitation program did not lead to either weight gain, improvement in physiological function, or better quality of life in patients with severe COPD." 11/01/2003 - "PATIENTS AND METHODS: We randomly assigned 63 male patients with COPD to receive on days 1, 15, 29, and 43 a deep IM injection of 50 mg of nandrolone decanoate (ND) [Deca-Durabolin; N.V. Organon; Oss, The Netherlands] in 1 mL of arachis oil, or 1 mL of arachis oil alone (placebo) in a double-blind design. " Order ALL the reference details at left...
5.	Chronic Kidney Failure (Chronic Renal Failure) 10/01/1997 - "We conclude that the combination of low-dose rHuEPO and nandrolone decanoate is effective treatment for the anemia of end-stage renal failure." 04/01/2001 - "The role of nandrolone decanoate in patients with end stage renal disease in the erythropoietin era." 01/01/1978 - "A double blind cross-over trial of Nandrolone decanoate (Decadurabolin) was carried out in 27 patients with anaemia due to end stage renal disease, stabilised on regular haemodialysis. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Steroids
2.	alvesin
3.	Methylprednisolone
4.	Testosterone (Sustanon)
5.	Calcium
6.	nandrolone decanoate (Decadurabolin)
7.	Tamoxifen
8.	Erythropoietin
9.	Calcitonin (Calcitonin, Eel)
10.	Nandrolone (Nortestosterone)

Related Therapies and Procedures

1.	Intramuscular Injections
2.	Renal Dialysis (Hemodialysis)
3.	Hormone Replacement Therapy (Therapy, Hormone Replacement)
4.	Combination Drug Therapy (Combination Chemotherapy)
5.	Highly Active Antiretroviral Therapy (HAART)

blog comments powered by Disqus

TREATMENT OPTIONS
for Anemia,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 1056 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$8.50 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$45.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>